SWOG S1207

Primary Category:

Treatment Protocols

Disease Category:

Adjuvant Breast, Breast



Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer. e^3 Breast Cancer Study-Evaluating Everolimus with Endocrine Therapy


S1207 is closed to accrual effective May , 2019.

Eligible for screening study DCP 001

Leave a Reply